Innovative therapies are rapidly shifting our paradigm of metabolic disease . Tirzepatide , along with several compounds , present potential possibilities in addressing conditions like type second hyperglycemia and obesity . While research are still in progress , early findings imply remarkable improvements in glucose management and physical loss